Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar)
European Heart Journal, 08/20/2012
Schou M et al. – Irrespective of the level of NT–proBNP stable HF patients on optimal medical therapy do not benefit from long–term follow–up in a specialized heart failure clinics (HFCs) in a publicly funded universal access healthcare system. Heart failure patients on optimal medical therapy with mild or moderate symptoms are safely managed by their personal general practitioner (GP).